Emerging Prognostic Biomarkers in Testicular Germ Cell Tumors: Looking Beyond Established Practice
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging Prognostic Biomarkers in Testicular Germ Cell Tumors: Looking Beyond Established Practice
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-11-28
DOI
10.3389/fonc.2018.00571
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systemic immune-inflammation index in germ-cell tumours
- (2018) Michal Chovanec et al. BRITISH JOURNAL OF CANCER
- Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy
- (2018) Christian Daniel Fankhauser et al. BRITISH JOURNAL OF CANCER
- Liquid Biopsy Using Whole Blood from Testis Tumor and Colon Cancer Patients—A New and Simple Way?
- (2018) Matthäus Majewski et al. HEALTH PHYSICS
- Integrated Molecular Characterization of Testicular Germ Cell Tumors
- (2018) Hui Shen et al. Cell Reports
- High β-1,4-Galactosyltransferase-I expression in peripheral T-lymphocytes is associated with a low risk of relapse in germ-cell cancer patients receiving high-dose chemotherapy with autologous stem cell reinfusion
- (2018) Verena Nilius et al. OncoImmunology
- c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors
- (2018) Katia Corano Scheri et al. Oncotarget
- Testicular cancer
- (2018) Liang Cheng et al. Nature Reviews Disease Primers
- Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation
- (2017) Stefanie Zschäbitz et al. EUROPEAN JOURNAL OF CANCER
- Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastases
- (2017) Y. Loriot et al. EUROPEAN JOURNAL OF CANCER
- Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours
- (2017) Klaus-Peter Dieckmann et al. EUROPEAN UROLOGY
- Perspectives on testicular germ cell neoplasms
- (2017) Liang Cheng et al. HUMAN PATHOLOGY
- High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience
- (2017) Nabil Adra et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine
- (2017) Liang Cheng et al. MODERN PATHOLOGY
- Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumor
- (2017) Kevin Litchfield et al. NATURE GENETICS
- Prognostic value of intratumoral carbonic anhydrase IX expression in testicular germ cell tumors
- (2017) Katarina Kalavska et al. Oncology Letters
- microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients
- (2017) Ton van Agthoven et al. CELLULAR ONCOLOGY
- Prognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors
- (2017) Michal Chovanec et al. Oncotarget
- Prognostic factors in patients with poor-risk germ-cell tumors: a retrospective analysis of the Indiana University experience from 1990 to 2014
- (2016) N. Adra et al. ANNALS OF ONCOLOGY
- Activity of immune checkpoint inhibition in platinum refractory germ-cell tumors
- (2016) S. Zschäbitz et al. ANNALS OF ONCOLOGY
- miR-223-3p regulates cell growth and apoptosis via FBXW7 suggesting an oncogenic role in human testicular germ cell tumors
- (2016) Jikai Liu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MicroRNA miR-371a-3p - A Novel Serum Biomarker of Testicular Germ Cell Tumors: Evidence for Specificity from Measurements in Testicular Vein Blood and in Neoplastic Hydrocele Fluid
- (2016) Klaus-Peter Dieckmann et al. UROLOGIA INTERNATIONALIS
- Prognostic value of serum carbonic anhydrase IX in testicular germ cell tumor patients
- (2016) Katarina Kalavska et al. Oncology Letters
- Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine
- (2016) Costantine Albany et al. Oncotarget
- Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors
- (2015) Z. Cierna et al. ANNALS OF ONCOLOGY
- Frequent PD-L1 expression in testicular germ cell tumors
- (2015) C D Fankhauser et al. BRITISH JOURNAL OF CANCER
- Circulating Serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as Biomarkers in Patients with Testicular Germ Cell Cancer
- (2015) Isabella Syring et al. JOURNAL OF UROLOGY
- Whole-exome sequencing reveals the mutational spectrum of testicular germ cell tumours
- (2015) Kevin Litchfield et al. Nature Communications
- A Nationwide Cohort Study of Stage I Seminoma Patients Followed on a Surveillance Program
- (2014) Mette Saksø Mortensen et al. EUROPEAN UROLOGY
- Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial
- (2014) Karim Fizazi et al. LANCET ONCOLOGY
- MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker
- (2014) M. Spiekermann et al. Andrology
- PARP expression in germ cell tumours
- (2013) Michal Mego et al. JOURNAL OF CLINICAL PATHOLOGY
- Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: A proof of principle
- (2013) Ad J.M. Gillis et al. Molecular Oncology
- Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors
- (2012) C. Massard et al. ANNALS OF ONCOLOGY
- MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours
- (2012) K-P Dieckmann et al. BRITISH JOURNAL OF CANCER
- Serum Levels of MicroRNAs miR-371-3: A Novel Class of Serum Biomarkers for Testicular Germ Cell Tumors?
- (2012) Gazanfer Belge et al. EUROPEAN UROLOGY
- Molecular pathology of lung cancer: key to personalized medicine
- (2012) Liang Cheng et al. MODERN PATHOLOGY
- Gene-Expression Signature Predicts Postoperative Recurrence in Stage I Non-Small Cell Lung Cancer Patients
- (2012) Yan Lu et al. PLoS One
- Epigenetic regulation ofNanogexpression by Ezh2 in pluripotent stem cells
- (2011) Aranzazu Villasante et al. CELL CYCLE
- NANOG promoter methylation and expression correlation during normal and malignant human germ cell development
- (2011) Daniel Nettersheim et al. Epigenetics
- Methylation of an intronic region regulates miR-199a in testicular tumor malignancy
- (2011) H-H Cheung et al. ONCOGENE
- Carcinoma in situ testis displays permissive chromatin modifications similar to immature foetal germ cells
- (2010) K Almstrup et al. BRITISH JOURNAL OF CANCER
- High DNA Methyltransferase 3B Expression Mediates 5-Aza-Deoxycytidine Hypersensitivity in Testicular Germ Cell Tumors
- (2009) M. J. Beyrouthy et al. CANCER RESEARCH
- Kinetics of tumor marker decline as an independent prognostic factor in patients with relapsed metastatic germ-cell tumors.
- (2009) M. MEGO et al. NEOPLASMA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started